Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics
Purpose. The two purposes of this study were evaluating preclinical pharmacokinetics of MI-219 and predicting clearance (CL) and volume of distribution at steady-state (Vdss) of MI-219 in humans. Methods. Pharmacokinetic studies were conducted on mice, rats, dogs, and monkeys. Human CL of MI-219 was...
Saved in:
Main Authors: | Peng Zou (Author), Nan Zheng (Author), Yanke Yu (Author), Shanghai Yu (Author), Wei Sun (Author), Donna McEachem (Author), Yongsheng Yang (Author), Lawrence X Yu (Author), Shaomeg Wang (Author), Duxin Sun (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2012-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2
by: Lee WS, et al.
Published: (2018) -
Preclinical study the pharmacokinetics of lithium ascorbate
by: A. V. Pronin, et al.
Published: (2016) -
In Vitro ADME, Preclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of RBx14255, a Novel Ketolide with Pharmacodynamics Against Multidrug-Resistant Bacterial Pathogens
by: Trdib Chaira, et al.
Published: (2020) -
Preclinical pharmacokinetic studies and prediction of human PK profiles for Deg-AZM, a clinical-stage new transgelin agonist
by: Xiaoting Gu, et al.
Published: (2024) -
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans
by: Min-Soo Kim, et al.
Published: (2023)